Trials / Completed
CompletedNCT02558790
L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD
L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD: An Open-label Pilot Study of Cognitive and Functional Effects
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
This study is a 12-week, open-label pilot study to test the effects of MMFS-201-301 on cognition and function in adults with ADHD. Subjects may enter the trial on a stable dose of medication for ADHD, and MMFS-201-301 will be given. Subjects who do not enter on a stable dose of ADHD medication will receive MMFS-201-301 alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | L-Threonic Acid Magnesium Salt (L-TAMS) |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2017-10-01
- Completion
- 2017-10-01
- First posted
- 2015-09-24
- Last updated
- 2018-05-14
- Results posted
- 2018-05-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02558790. Inclusion in this directory is not an endorsement.